St. Luke’s offers advanced prostate cancer detection and treatment with KOELIS and Da Vinci RALP

St. Luke’s Medical Center’s (SLMC) Institute of Urology is a leading medical institute for prostate cancer treatment. The Institute, led by highly trained urologists, is equipped with state-of-the-art prostate cancer care technology, particularly the Da Vinci Robot-assisted Laparoscopic Prostatectomy (RALP) and the KOELIS MRI Ultrasound Prostate Fusion Biopsy.

KOELIS and Da Vinci RALP go hand-in-hand throughout the medical journey of a patient diagnosed with prostate cancer. KOELIS MRI is a world-renowned targeted MRI fusion biopsy procedure that provides precise and recorded biopsies. The KOELIS MRI fusion biopsy has 46% more detection of significant prostate cancer compared to a conventional prostate biopsy. This significantly decreases the need for a second biopsy, making it cost-effective.

The procedure involves an MRI and an ultrasound-guided biopsy done either via transrectal or transperineal approach. The KOELIS MRI ultrasound fusion biopsy of the prostate (unless otherwise contraindicated) is done as an outpatient procedure.

KOELIS’ advanced technology provides confidence in prostate cancer diagnosis and management through its precise and accurate prostate biopsy. Early and accurate prostate diagnosis is crucial to the efficient management of prostate cancer and its potential cure.

While KOELIS is used to diagnose cancer, on the other hand, Da Vinci RALP is used to treat prostate cancer. RALP is a robot-assisted minimally invasive surgical procedure that aims to remove the prostate and completely remove cancer cells along with it. By using a highly advanced robot, the surgeon has greater visualization, dexterity, and precision in the surgery.

Unlike humans, the robotic technology used in RALP have more flexible wrists that can create extremely small but precise incisions and access hard-to-reach spaces with greater care and accuracy.

The benefits of Da Vinci RALP for the patient include better preservation of urinary continence and erectile function, shorter hospital stay, earlier recovery, fewer complications, lesser blood loss and minimal risk of infection. At SLMC-Global City, urologists have performed over 1,000 successful robotic surgeries for patients with prostate cancer.

Prostate cancer is the third most common cancer among men in the Philippines. Early detection is key in preventing its progression, but for those who are experiencing prostate cancer in the later stages, hope is not lost.

Through KOELIS and Da Vinci RALP, St. Luke’s highly trained urologists can provide men with a fighting chance against prostate cancer. The two technologies of the Institute not only help doctors save lives, but also provide comfort and trust in doing so.

For inquiries on prostate cancer screening and treatment, please contact the Institute of Urology through at 8-789 7700 loc. 7044 (SLMC-Global City) or at 8-723 0101 loc. 5425 (SLMC-Quezon City)